Home/Captura Biopharma/Dr. Gary Barnette, Ph.D.
DG

Dr. Gary Barnette, Ph.D.

Regulatory

Captura Biopharma

Captura Biopharma Pipeline

DrugIndicationPhase
C2E2Treatment of internal radioactive contamination (e.g., from nuclear accidents, radiological incidents)Pre-clinical